QuiaPEG Pharmaceuticals Holding (OM:QUIA BTU) - Stock Price, News & Analysis

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

QUIA BTU Stock Overview

Engages in the research, development, and commercialization of medicines based on Uni-Qleaver, a drug delivery platform.

About the company

QUIA BTU fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Rewards

Risk Analysis

Earnings have declined by 20% per year over past 5 years

Does not have a meaningful market cap (SEK4M)

Shareholders have been substantially diluted in the past year

Shares are highly illiquid

+ 2 more risks

Quia Pharma AB (publ) Competitors

European Institute of Science

NGM:EURI B

SEK 1.8m

Diagonal Bio

OM:DIABIO

SEK 3.8m

Genetic Analysis

NGM:GEAN

NOK 36.5m

Spago Nanomedical

OM:SPAGO

SEK 86.4m

Price History & Performance

Summary of all time highs, changes and price drops for QuiaPEG Pharmaceuticals Holding
Historical stock prices
Current Share Price	SEK 0.011
52 Week High	SEK 0.059
52 Week Low	SEK 0.0092
Beta	0.95
11 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	-38.98%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	QUIA BTU	SE Biotechs	SE Market
7D	8.0%	1.3%	1.9%
1Y	n/a	30.1%	24.3%

Return vs Industry: Insufficient data to determine how QUIA BTU performed against the Swedish Biotechs industry.

Return vs Market: Insufficient data to determine how QUIA BTU performed against the Swedish Market.

Price Volatility

Is QUIA BTU's price volatile compared to industry and market?
QUIA BTU volatility
QUIA BTU Average Weekly Movement	n/a
Biotechs Industry Average Movement	9.1%
Market Average Movement	5.6%
10% most volatile stocks in SE Market	11.7%
10% least volatile stocks in SE Market	3.2%

Stable Share Price: QUIA BTU's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine QUIA BTU's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2004	4	Marcus Bosson	www.quiapeg.com

QuiaPEG Pharmaceuticals Holding AB (publ), a biotech company, engages in the research, development, and commercialization biopharmaceutical products for the treatment of metabolic disorders. The company develops biopharmaceuticals based on PEGylation technology platform, which is applicable on proteins, peptides, and small molecules or oligonucleotides. Its product pipeline includes QPG-1030 (pegylated teduglutide) for the treatment of short bowel syndrome, and QPG-1029 under pre-clinical development for stable plasma concentration, as well as antibody-drug conjugates being developed using the company’s Uni-Qleaver technology-platform.

Quia Pharma AB (publ) Fundamentals Summary

How do QuiaPEG Pharmaceuticals Holding's earnings and revenue compare to its market cap?
QUIA BTU fundamental statistics
Market cap	SEK 3.70m
Earnings (TTM)	-SEK 20.09m
Revenue (TTM)	SEK 5.57m

0.7x

P/S Ratio

-0.2x

P/E Ratio

Is QUIA BTU overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
QUIA BTU income statement (TTM)
Revenue	SEK 5.57m
Cost of Revenue	SEK 2.24m
Gross Profit	SEK 3.33m
Other Expenses	SEK 23.42m
Earnings	-SEK 20.09m

Last Reported Earnings

Dec 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)	-0.085
Gross Margin	59.81%
Net Profit Margin	-360.41%
Debt/Equity Ratio	628.4%

How did QUIA BTU perform over the long term?

See historical performance and comparison